JACK SAUNDERS: Open Payments
NPI 1801175807 · WEST JORDAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 29 payments from 11 companies in 2025. Trend: 2023 $518 · 2024 $753 · 2025 $696
Food & beverage: $528Education: $168
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 9 | $234 |
| Janssen Biotech, Inc. | 3 | $186 |
| Novartis Pharmaceuticals Corporation | 3 | $53 |
| Lilly USA, LLC | 2 | $45 |
| ABBVIE INC. | 2 | $36 |
| Arcutis Biotherapeutics, Inc. | 2 | $35 |
| Organon LLC | 4 | $31 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $22 |
| Botanix SB Inc | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: Bimzelx, TREMFYA, COSENTYX, TALTZ, SKYRIZI, Zoryve, ILUMYA, SOFDRA.
Industry payments across UT — which companies pay providers there.
